MBX Biosciences(MBX)
CARMEL, INBiotechnology
Focus: MBX Biosciences is a public biotechnology company focused on hormone analogues for rare endocrine diseases, with a lean pipeline spanning hypoparathyroidism, postbariatric hypoglycemia, and obesity indications. Based in Carmel, IN, the company operates at mid-cap scale with 11 active job openings and a specialized focus on endocrinology and rare disease markets.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Total Funding
$130M
Open Jobs
11-1 this month
Stable — net -1 jobs in 30d
5 added, 6 removed. Backfill posture.
Should You Work at MBX Biosciences?
AI assessmentBest fit for early-career clinical, QA, or R&D professionals willing to bet on rare disease expertise and Phase 3 catalysts in exchange for pre-revenue risk and minimal company scale.
Why Work Here
- Advancing to Phase 3 with Canvuparatide for hypoparathyroidism, a rare disease with limited treatment options and potential for meaningful commercial impact.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
MBX 2109
Renal ImpairmentClinical Trials (1)
NCT06496217Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function
Phase 1Help build intelligence for MBX Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.